Nano-X Imaging Ltd. (NNOX): Total Liabilities
$22.43M
As of 2025-12-31
-15.6%
3-year compound annual growth
+32.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $22.43M | +7.4% | 2026-04-30, Balance as of period end |
| 2024-12-31 | $20.88M | -9.7% | 2026-04-30, Balance as of period end |
| 2023-12-31 | $23.13M | -37.9% | 2025-04-09, Balance as of period end |
| 2022-12-31 | $37.25M | -47.5% | 2024-04-22, Balance as of period end |
| 2021-12-31 | $71.02M | n/m | 2023-05-01, Balance as of period end |
| 2020-12-31 | $5.40M | -73.8% | 2022-05-02, Balance as of period end |
| 2019-12-31 | $20.65M | n/a | 2021-04-06, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | 2025-12-31 | $22.43M | +7.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $4.90M | +82.4% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $14.26M | +44.6% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $3.08M | +4.4% |
| LogicMark, Inc. (LGMK) | 2025-12-31 | $2.22M | +9.2% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $5.57M | +13.6% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $92.96M | -16.1% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $39.41M | +10.5% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $11.04M | +12.5% |
Compare NNOX, CV, HYPR, ESMC side by side · Screen every company in X-Ray Apparatus & Tubes & Related Irradiation Apparatus ↗